2 result(s) displayed (1 - 2 of 2):

CFO's path from Genentech to Facebook (from Corporate Dealmaker)

For some people, Roche Holding AG's takeover of Genentech Inc. was bad news. For others, good. Put Facebook Inc. CEO Mark Zuckerberg in the latter category. After Roche took over, the biotech giant didn't need its own CFO, which made David Ebersman available to become CFO at the  social networking...

Posted on June 30, 2009 9:56 AM

Genentech wanted $112 a share, Roche claims (from Corporate Dealmaker)

After nearly five months of stalled negotiations, Genentech Inc. officials told their counterparts at Roche Holding AG in December they would accept a buyout offer of $112 a share, according to documents filed late Monday by Roche.The document released Monday is Roche's official tender offer to Genentech shareholders, whom the...

Posted on February 9, 2009 5:29 PM